Terland O, Flatmark T (iunie 1999). „Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles”. Neuropharmacology. 38 (6): 879–82. doi:10.1016/s0028-3908(98)00233-0. PMID10465691.Mentenanță CS1: Utilizează parametrul autori (link)
Wilder-Smith CH, Schimke J, Osterwalder B, Senn HJ (). „Cinnarizine for prevention of nausea and vomiting during platin chemotherapy”. Acta Oncologica. 30 (6): 731–4. doi:10.3109/02841869109092448. PMID1958394.Mentenanță CS1: Utilizează parametrul autori (link)
Pianese CP, Hidalgo LO, González RH, Madrid CE, Ponce JE, Ramírez AM, Morán LM, Arenas JE, Rubio AT, Uribe JO, Abiuso J, Hanuch E, Alegría J, Volpi C, Flaskamp R, Sanjuán AP, Gómez JM, Hernández J, Pedraza A, Quijano D, Martínez C, Castañeda JR, Guerra OJ, F GV (mai 2002). „New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study”. Otology & Neurotology. 23 (3): 357–63. doi:10.1097/00129492-200205000-00023. PMID11981396.Mentenanță CS1: Utilizează parametrul autori (link)
Arab SF, Düwel P, Jüngling E, Westhofen M, Lückhoff A (iunie 2004). „Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine”. Naunyn-Schmiedeberg's Archives of Pharmacology. 369 (6): 570–5. doi:10.1007/s00210-004-0936-3. PMID15138660.Mentenanță CS1: Utilizează parametrul autori (link)
drugbank.ca
„Cinnarizine”. DrugBank - Canadian Institutes of Health Research. Accesat în februarie 2020.
cinnarizine (în engleză), Global Substance Registration System, accesat în
nih.gov
ncbi.nlm.nih.gov
Terland O, Flatmark T (iunie 1999). „Drug-induced parkinsonism: cinnarizine and flunarizine are potent uncouplers of the vacuolar H+-ATPase in catecholamine storage vesicles”. Neuropharmacology. 38 (6): 879–82. doi:10.1016/s0028-3908(98)00233-0. PMID10465691.Mentenanță CS1: Utilizează parametrul autori (link)
Nicholson AN, Stone BM, Turner C, Mills SL (iunie 2002). „Central effects of cinnarizine: restricted use in aircrew”. Aviation, Space, and Environmental Medicine. 73 (6): 570–4. PMID12056673.Mentenanță CS1: Utilizează parametrul autori (link)
Wilder-Smith CH, Schimke J, Osterwalder B, Senn HJ (). „Cinnarizine for prevention of nausea and vomiting during platin chemotherapy”. Acta Oncologica. 30 (6): 731–4. doi:10.3109/02841869109092448. PMID1958394.Mentenanță CS1: Utilizează parametrul autori (link)
Pianese CP, Hidalgo LO, González RH, Madrid CE, Ponce JE, Ramírez AM, Morán LM, Arenas JE, Rubio AT, Uribe JO, Abiuso J, Hanuch E, Alegría J, Volpi C, Flaskamp R, Sanjuán AP, Gómez JM, Hernández J, Pedraza A, Quijano D, Martínez C, Castañeda JR, Guerra OJ, F GV (mai 2002). „New approaches to the management of peripheral vertigo: efficacy and safety of two calcium antagonists in a 12-week, multinational, double-blind study”. Otology & Neurotology. 23 (3): 357–63. doi:10.1097/00129492-200205000-00023. PMID11981396.Mentenanță CS1: Utilizează parametrul autori (link)
Arab SF, Düwel P, Jüngling E, Westhofen M, Lückhoff A (iunie 2004). „Inhibition of voltage-gated calcium currents in type II vestibular hair cells by cinnarizine”. Naunyn-Schmiedeberg's Archives of Pharmacology. 369 (6): 570–5. doi:10.1007/s00210-004-0936-3. PMID15138660.Mentenanță CS1: Utilizează parametrul autori (link)